Search information pages
Molecular Pain open access policy
Every peer-reviewed research article appearing in any journal published by BioMed Central is "open access", meaning that:
- The article is universally and freely accessible via the Internet, in an easily readable format and deposited immediately upon publication, without embargo, in an agreed format - current preference is XML with a declared DTD - in at least one widely and internationally recognized open access repository (such as PubMed Central).
- The author(s) or copyright owner(s) irrevocably grant(s) to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the research article in its entirety or in part, in any format or medium, provided that no substantive errors are introduced in the process, proper attribution of authorship and correct citation details are given, and that the bibliographic details are not changed. If the article is reproduced or disseminated in part, this must be clearly and unequivocally indicated.
Molecular Pain is committed permanently to maintaining this open access publishing policy, retrospectively and prospectively, in all eventualities, including any future changes in ownership. Molecular Pain has established an independent Advisory Board. If and when a change of ownership should be considered, the Advisory Board will be asked to judge and advise whether sufficient guarantees to continue a policy of unconditional open access for research articles are being offered and agreed by any prospective new owner. Molecular Pain will not enter into a change of ownership agreement unless the Advisory Board accepts these guarantees.
Open access articles in Molecular Pain's journals are identified by this logo: